CD8A and acute myeloid leukemia: CD8 T cells purified from PBMCs of HLA-A*0201 AML patients were co-cultured in vitro with T2 cells (used as antigen-presenting cells) that were pulsed with HLA-A*0201-binding WT-1126-134 peptide.